Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006
about
ACSC Indicator: testing reliability for hypertension2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations.Hypertension: are you and your patients up to date?Hypertension and type 2 diabetes: what family physicians can do to improve control of blood pressure--an observational study.2010 Canadian Hypertension Education Program recommendations: An annual update.Canadian efforts to prevent and control hypertension.What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative studyRegional variations in not treating diagnosed hypertension in Canada.Old habits die hard: a nationwide utilization study of short-acting nifedipine in Taiwan.Combination therapy as initial treatment for newly diagnosed hypertension.Prevalence and management of hypertension in primary care practices with electronic medical records: a report from the Canadian Primary Care Sentinel Surveillance Network.Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative.Do recommendations for the management of hypertension improve cardiovascular outcome? The canadian experience.Tackling the burden of hypertension in Canada: encouraging collaborative carePrinted educational messages fail to increase use of thiazides as first-line medication for hypertension in primary care: a cluster randomized controlled trial [ISRCTN72772651].2009 Canadian Hypertension Education Program recommendations: an annual update.Effective population-wide public health interventions to promote sodium reductionβ-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.New prescriptions of spironolactone associated with angiotensin-converting-enzyme inhibitors and/or angiotensin receptor blockers and their laboratory monitoring from 2001 to 2008: a population study on older people living in the community in Italy.Benefits and pitfalls of cardiovascular medication in seniors.Antihypertensive drugs and the risk of fall injuries: a systematic review and meta-analysis.Isometric Handgrip as an Adjunct for Blood Pressure Control: a Primer for Clinicians.Association between colorectal polyps and hypertension treatment.Comparison of the Effect of Thiazide Diuretics and Other Antihypertensive Drugs on Central Blood Pressure: Cross-Sectional Analysis Among Nondiabetic Patients.Understanding GLP-1 analogs and enhancing patients success.Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program.Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands.S’attaquer au fardeau de l’hypertension au Canada: Encourager les soins en collaboration.Change of the management of treated hypertensive patients with or without diabetes in Japan.The impact of the Canadian Hypertension Education Programme in its first decade.Antihypertensive Medicines Prescriptions before and after the Nigeria Hypertension Society Guidelines and Prescriber's Awareness of the Guideline.Long term outcomes of cluster randomized trial to improve cardiovascular health at population level: The Cardiovascular Health Awareness Program (CHAP)
P2860
Q33837575-D993325A-017F-4C6A-A35A-CCB9A0C3DCEDQ33916665-605D2C9E-4955-493C-9CE0-AA88A0F5A3EAQ33916689-0A33A7B5-771C-48DE-A0EC-CCCB70CD2440Q33990899-C40C3DEF-8418-4445-8409-08CC2BC0A141Q34066861-5CE6E613-C8B9-4BED-9C41-72695EE0AA1CQ34175231-D8A8650D-E2D7-452F-B716-B7FC4CBCF60EQ34178297-26F6F4CB-D5E6-4F4C-BF30-648916008E7DQ34196690-3E230972-5F11-465F-A8EC-B3F636CD99ECQ35123011-E9C7EE08-2540-41BB-B51B-9D88FB51BA3CQ35156143-E582398F-E14E-47D2-A4B2-DEAC910BE205Q35241224-3B004DA3-DF3F-4863-903D-11F02E85398EQ35343974-762E833A-B754-48F6-9AC3-7A0E85080EA5Q35504206-C1DF06B3-F58C-4938-A12F-1F4AAD425D40Q37014407-BABFE7BB-07A2-4FC5-AFF9-E6D5A5CE1C08Q37263256-E6C18EC0-7250-4730-B57E-BF4066F9E12EQ37281600-8D510A6A-25F8-4DDE-8AA0-0C4BE409550DQ37394056-D823266C-B137-4E52-88BF-53195BAA2BCAQ37849264-0372DED4-E316-44C7-B3FD-042B4CA426FFQ38045164-11FEBFFF-A08D-417C-BF21-BA2BE7C9B1C8Q38120998-8F6B8D5D-CC27-4EFE-83CC-2ADBD451A6C5Q38139662-0CEEC45F-2B4D-45F0-9167-109495232A66Q39320266-71129BC4-8A58-4F41-B055-BB8320835D6AQ40554318-99C0944F-F6B2-411E-B70D-593BF267FD38Q40718396-797E2562-BA9A-4E26-8EE9-89C5CF707C7EQ42927083-AEC9B37B-F1DD-424E-924A-1CB3EBA02B9EQ43795259-1C4BAE89-E536-435A-876B-E435D52A8FD3Q44756155-1008E1DD-2F9B-4EAD-A960-BE28796F5508Q45737352-35A23D5B-0311-4971-92D2-C34AF485277BQ45885930-47332DC0-8B6A-4CC1-B70E-EFCEF8793153Q46219853-C337A046-03C6-475E-BF67-0A8AB1FF9BE1Q53796531-10BBA9ED-158E-4CD9-91C5-3830AC15E882Q55487906-1A9AF435-CA2F-422C-A815-4A1CCDCC4F7BQ58762175-AABCB2C0-DFFF-4986-BF82-75781C478ACF
P2860
Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trends in antihypertensive dru ...... n Canada between 1996 and 2006
@en
Trends in antihypertensive dru ...... Canada between 1996 and 2006.
@nl
type
label
Trends in antihypertensive dru ...... n Canada between 1996 and 2006
@en
Trends in antihypertensive dru ...... Canada between 1996 and 2006.
@nl
prefLabel
Trends in antihypertensive dru ...... n Canada between 1996 and 2006
@en
Trends in antihypertensive dru ...... Canada between 1996 and 2006.
@nl
P2093
P2860
P1476
Trends in antihypertensive dru ...... n Canada between 1996 and 2006
@en
P2093
Brenda R Hemmelgarn
Finlay A McAlister
Guanmin Chen
Nadia Khan
Norm Campbell
Robin Walker
P2860
P304
P356
10.1016/S0828-282X(08)70627-5
P577
2008-06-01T00:00:00Z